ArticleJournal of cellular and molecular medicine2019

Trans-3,5,4´-trimethoxystilbene reduced gefitinib resistance in NSCLCs via suppressing MAPK/Akt/Bcl-2 pathway by upregulation of miR-345 and miR-498.

Min Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.